Posted on Apr 10, 2012 By Jackson Allen Williams, LLP
The FDA announced to today that the drug labels for drosperinone-containing birth control pills, including Yasmin and Yaz, will be changed to include warnings regarding the increased risk of blood ...
Continue reading "FDA Announces Label Change for Yasmin and Yaz" »
Posted on Nov 21, 2011 By Jennifer Williams
An article out today on Bloomberg.com states that units of Bayer AG, Germany's largest drug maker, may have promoted its birth control pills, Yasmin and Yaz, for unapproved uses. The article also ...
Continue reading "New Article Suggests Bayer May Have Promoted Yaz/Yasmin for Unapproved Use" »
Posted on Oct 27, 2011 By Jennifer Williams
The FDA released the report today from its study of the relative risks of various combined hormonal contraceptives (CHCs). The study compared recently marketed CHCs including Yasmin/Yaz, Ortho Evra ...
Continue reading "Report from FDA-funded study confirms increased risk of VTEs in users of Yasmin and Yaz" »